Stem cell therapy - Wu Stem Cells Medical Center - A Leading Medical Center for Stem Cell Therapy

| All Others

eg.stem cell, stem cell treatment

As the most basic building blocks of the human body, stem cells are characterized by their ability to differentiate and mature into other types of cells with specialized functions. They are also known for their ability to self-generate, a phenomenon where they divide and produce more stem cells. During early childhood, stem cells may develop into a variety of different cell types. They are also capable of replenishing other cells, acting as the body's own automatic repair system. This ability makes them an ideal treatment for many diseases; this treatment is called stem cell therapy.

[News] Adult Stem Cells Applied to Cancer Therapy
The adult stem cell company Vitro Biopharma has announced pending patent applications on proprietary cell-based cancer therapies that are developed from human adult stem cells. Specifically, the therapies incorporate the natural properties of a specific type of adult stem cell known as mesenchymal stem cells (MSCs), a highly potent stem cell that is commonly found in bone marrow, adipose (fat) tissue and umbilical cord blood.

[News] Adult Stem Cells Treat Heart Failure
In 2007, Thomas Clegg was diagnosed with dilated cardiomyopathy, a condition in which the left ventricle of the heart becomes abnormally enlarged. At that time, his ejection fraction - a measure of the heart's efficiency at pumping blood - was around 9 (nine) percent, whereas a normal ejection fraction is considered to be between 50 and 65%, or higher.

[News] BrainStorm Develops New ALS Therapy
The adult stem cell company BrainStorm Cell Therapeutics announced today that it has entered into an agreement with Protein Production Services, a leading manufacturing contractor, in order to begin production of its therapeutic adult stem cell product for the treatment of ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig's disease). The

[News] Adult Stem Cell Clinical Findings Presented at European Conference
This week in Barcelona, at the 10th annual congress of the European Society of Cardiology, the U.S. company TCA Celluar Therapy is presenting its latest clinical findings on its own proprietary adult stem cell therapies in the treatment of two particular diseases, namely, critical limb ischemia (CLI) and refractory coronary ischemia (CI). TCA has already evaluated its therapies for both conditions in U.S. FDA-approved clinical trials.

[News] The Media is Criticized for Embryonic Stem Cell Bias
Not surprisingly, an organization that is focused on culture and the media issues a statement in which members of the U.S. media are criticized for their irresponsible bias in favor of embryonic stem cell research, while deliberately and systematically ignoring adult stem cell accomplishments.

[News] Neuralstem Awarded Adult Stem Cell Patent
The company Neuralstem has announced today that it has been awarded a patent for its latest proprietary technology for an adult stem cell therapy that can be used in the treatment of neurological diseases.

[News] Race Horse Returns to Racing After Adult Stem Cell Therapy
Lava Man, the 8-year-old gelding who retired from racing last year, is now returning to racing and indefinitely postponing his retirement after showing significant improvement from autologous adult stem cell therapy.

[News] NIH Awards Stem Cell Grant for the Study of Autism
The National Institutes of Health (NIH) have announced the awarding of a $3 million grant to Children's Hospital of Orange County (CHOC) in California to study stem cells in autistic children.

[News] Stem cell therapy maker Aldagen files for IPO
The adult stem cell company Aldagen Inc, from Durham North Carolina announced today that it has filed a registration with the Securities Exchange Commission for an initial public offering with a potential value of $80.5 million. Details regarding price range or shares to be issues were not disclosed.

[News] Stem cell therapy, a promising novel endeavor for neurological disorders
STEM CELL THERAPY has emerged as a promising novel therapeutic endeavor for traumatic brain injury, spinal cord injury, stroke, and epilepsy in experimental studies. A few preliminary clinical trials have further supported its safety and early efficacy after transplantation into humans.

[News] Stem Cell Therapy May Offer Hope For Acute Lung Injury
Acute lung injury is a major cause of death that can be caused by several conditions. Viral infections such as SARS, blunt for tissue trauma, and bacteria sepsis have all been associated with lung injury. It is believed that approximately 75,000 deaths per year in the United States alone occur because of this. Deaths are occur primarily in the intensive care units, and to date, there has been no treatment developed that works.

[News] Stem Cell Therapy Aids the Return of Lava Man
Lava Man is a race horse that has had quite a career: he has earned more than $5.2 million and was considered one of the top racehorses in North America. Unfortunately, the recent past has not been to kind to him.

[News] Using Stem Cell Therapy To Tackle HIV
A novel stem cell therapy that arms the immune system with an intrinsic defence against HIV could be a powerful strategy to tackle the disease.

[News] International Stem Cell Corporation Formalizes Stem Cell-Based Eye Care Programs Into Cytovis
Together these programs will leverage external and internal development, regulatory and commercial expertise in cellular ophthalmology to form a focused portfolio of complementary product candidates designed to address high unmet medical needs with apparent pharmacoeconomic and quality of life benefits.

[News] Biomedical Scientist Brings Stem Cell Research to University
A heart patient's own skin cells soon could be used to repair damaged cardiac tissue thanks to pioneering stem cell research of the University of Houston's newest biomedical scientist, Robert Schwartz.

[News] US FDA allows first test of human stem cell therapy

[News] University of Pittsburgh Receives Two NIH Grants for Novel Stem Cell Research
Scientists at the University of Piitsburgh have announced today the awarding by NIH (the National Institutes of Health) of two separate grants totalling more than $5 million. One of the grants is for the study of embryonic stem cell differentiation, while the other is for investigating a new method of growing adult stem cells on lymph nodes.

[News] Multiple Sclerosis Patients Improve After Adult Stem Cell Therapy
Physicians at Northwestern University in Chicago have reported dramatic improvement in patients who were treated with adult bone marrow stem cells for multiple sclerosis (MS).

[News] More Veterinary Success Seen With Adult Stem Cells
Even at five years of age, Lucy the Labradoodle was suffering from rheumatoid arthritis in her hind legs. But now, after receiving autologous adult stem cell therapy, she is showing significant improvement. According to her owner, Carol Fischman of Vero Beach, Florida, "We didn't think she'd live anywhere near this long, and I know it's because of the stem cells."

[News] Physical Exercise Stimulates Neural Stem Cells and Sharpens Cognitive Function
A familiar Latin adage attributed to the second century Roman poet Juvenal states: "Mens sana in corpore sano" (a healthy mind in a healthy body). Nearly 2 millennia later, scientists are still discovering new scientific proof of such timeless wisdom.

[News] Scientists Regenerate Various Tissue Types by Stimulating the Body's Own Stem Cells
In a series of experiments that are founded upon the success of Genzyme's proprietary drug, Mozobil (see "Genzyme Receives FDA Approval for Mozobil", December 15, 2008), scientists at the Imperial College of London have demonstrated the unsuspected regenerative potency of endogenous, autologous adult stem cells.

[News] Fetal Stem Cell Therapy Could Prove Fatal
An Israeli boy who suffers from a rare, often fatal genetic disease known as ataxia telangiectasia (A-T) has developed a tumor that was directly traced to the fetal stem cell therapy that he received.

[News] Heart Patients Report Dramatic Improvement with Adult Stem Cell Therapy in Clinical Trials
Aaron Cathcart was told by his doctor that he barely had a year to live, because his heart was so weak that he would not be able to survive surgery. That was over two years ago.

[News] Adult Stem Cell Therapy for Diabetes Shows Progress
Once again, the biotech company Opexa Therapeutics announces strong preclinical data for its proprietary diabetes therapy, developed from autologous adult stem cells. The new study demonstrates that adult stem cells harvested from the mononuclear cells of peripheral blood are differentiable into pancreatic-like cells, which mimic the morphology and function of the beta islet cell clusters of the pancreas in their ability to secrete insulin, glucagon and somatostatin, as well as in the expression of pancreatic and endocrine-specific biomarkers and in the high levels of C-peptide, a byproduct of insulin synthesis.

[News] Man's Best Friend Improves With Adult Stem Cell Therapy
At his home on the New Jersey shore, Higgins was suffering from age-related arthritis. A 9-year-old Golden Retriever, he then underwent a veterinary procedure at the Toms River Animal Hospital in which his own adult canine stem cells were used as his therapy. Now, Higgins is once again pain-free and back to his regular self.

[News] Adult Stem Cell Companies Seen as Profitable Investment
While religious groups debate the various ethical issues of embryonic versus adult stem cells, and researchers debate the various scientific issues, financial analysts are not debating at all. From a purely monetary perspective, it is adult stem cells, not embryonic stem cells, which constitute a sound investment.

[News] Adult Stem Cells Treat Scleroderma
Mike George, a retired junior high school principal, had been suffering from an advanced case of systemic scleroderma.

[News] Cord Blood America Highlights 2009 Stem Cell Progress
Cord Blood America Inc. (CBAI), one of the largest providers in the world of umbilical cord blood stem cell preservation, reviews its accomplishments thus far in 2009. Even though the year is only half over, CBAI considers its achievements thus far in 2009 to be among the most significant in the company's history. Some of its accomplishments in the first half of this year are described herein.

[News] Stem Cell Tourism on the Rise
In any commercial endeavor, caveat emptor must be the consumer's guiding principle, and the medical profession is no exception to this rule. Now, as patients in increasing numbers continue to travel outside of their own countries in search of stem cell therapies that are only available in foreign lands, increasing problems and dangers are being reported.

[News] Placental Stem Cells Treat Lung Disease
Scientists at the Fondazione Poliambulanza-Instituto Ospelaliero in Brescia, Italy have used placental adult stem cells in the treatment of fibrotic lung diseases in laboratory animals.

[News] Genzyme Receives EU Approval for Adult Stem Cell Mobilization Product

The biotechnology giant Genzyme Corporation announced today that it has received regulatory approval from the European Commission for the commercial marketing of one of its products, Mozobil. A proprietary, injectable formulation of plerixa, Mozobil stimulates the mobilization and migration of the body's own adult, hematopoietic stem cells out of the bone marrow and into the peripheral blood where the cells can be easily collected. The

[News] DARA and America Stem Cell Announce Strategic Alliance
Today DARA BioSciences announced a strategic partnership with America Stem Cell Inc. (ASC) for the R&D of transplants in which the adult stem cells known as hematopoietic stem cells (HSCs) are used. The announcement represents a logical continuation of preclinical studies in which dipeptidylpeptidase (DPPIV) inhibitors were found to improve the efficacy of HSC transplantation, which is often employed in the treatment of many malignant as well as non-malignant hematological disorders.

[News] Equine Stem Cell Technique to be Tested in People
Achilles tendinopathies can cause severe distress in humans, but in horses such conditions can be fatal. Now, after having treated over 1,500 race horses with an autologous adult stem cell therapy that has demonstrated both safety and efficacy in the horses, researchers will begin testing the procedure on humans.

[Q&A] How do I know if I am a good candidate for stem cell therapy?

The first step is to send us your medical records and diagnostic test results. We will then analyze your case. If your disease or disorder does not have a specific treatment program, and the symptoms become increasingly serious, with severe neurological functioning damage, and biotherapy could help with nerve remodeling, improve functioning, change the quality of your life and prolong it, then we will suggest you have stem cell treatment if you don't have any contraindications.

[Q&A] What are stem cells and how do they work to treat various diseases?

[Q&A] What other drugs does the doctor combine with the stem cells for therapy?
The stem cell therapy is part of the whole treatment. During pre-operation we will use medication to improve the brain's microenvironment in order to make sure the injected stem cells can survive inside the body; During post-operation some medication will be used to protect the stem cells from being self-eliminated, and to help the stem cells locate, proliferate and differentiate in the damaged area. At the same time we combine rehabilitation training to help the stem cells develop the desired functions.

[Doctor Blogs] The long-term role of stem cell therapy - 11/02/2009

[Doctor Blogs] Hailey tried to speak! - 03/20/2009

Hailey's mouth opened a little more and her tongue moved after Miranda, her mother, told her to say hi to me. It was obvious that Hailey was saying hi to me even though her voice was not loud enough to be heard. "She tried to speak! I can see that," I said.

[Case Analysis] Stem Cell Therapy for Cerebral Palsy (June 22, 2009) Drs. Xi, Wang and Wu
Infantile cerebral paralysis (young child brain paralysis) refers to non-progressive brain injuries which occur during the perinatal period.

[Case Analysis] Stem Cell Therapy for Multiple Sclerosis (March 26, 2009) Drs. Liu, Wang and Wu
The patient is a 43-year-old male, he presented progressive motor disturbance of his four limbs for 20 years, and his symptoms have become more aggravated during the past 7 months. He was diagnosed with MS (multiple sclerosis).

[Case Analysis] Stem Cell Therapy for Brain Injury (April 7, 2009) Drs. Peng, Wang and Wu

[Case Analysis] Stem Cell Therapy for Batten's Disease (April 30, 2009) Drs. Xi, Wang and Wu

NCL (neuronal ceroid lipofuscinosis) is a kind of inherited neural degenerative disease affecting mainly children and only occasionally seen in adults. It is an autosomal recessive inheritance neural system disorder. In 1826, Dr. Stengel first discovered the disease and developed the concept of CL (ceroid lipofuscinosis).

[Case Analysis] Stem Cell Therapy for Amyotrophic Lateral Sclerosis (May 4, 2009) Drs. Xu, Wang and Wu
Patient is a 63-year-old male, he was presented as having progressive weakness of his 4 limbs, and continual weight loss for more than 2 years, the patient has had swallowing difficulties for about 3 months.

[Case Analysis] Stem Cell Therapy for Chronic Renal Insufficiency (May 20, 2009) Drs. Xu, Wang and Wu
Patient is a 56-year-old male and UK citizen; he was presented with oliguria and edema for past 5 years. He was diagnosed with chronic renal insufficiency. Patient had a medical history of hypertension for more than 10 years.

[Case Analysis] Stem Cell Therapy for Multiple System Atrophy (May 31, 2009) Dr. Wang and Dr. Wu
MSA (Multiple System Atrophy) is a kind of multiple CNS degeneration and atrophy with no clear cause. The following is a case of MSA that we were successful in treating.

[Case Analysis] Stem Cell Therapy for RA and Ankylosing Spondylitis (May 31, 2009) Drs. Xu, Wang and Wu
Stem Cell Therapy for RA and Ankylosing Spondylitis.Patient is a 36 year old female, she was presented with swelling and pain of the joints which she has suffered for more than 10 years, the symptoms became more aggravated more than 1 year ago. She was diagnosed with Rheumatoid Arthritis (RA).

[Case Analysis] Stem Cell Therapy for Spinal Cord Injury (March 30, 2009) Drs. Peng, Wang and Wu

The patient is a 57-year-old male, he presented as having motor and sensor disturbance of his lower limbs, together with urinary and fecal incontinence for 2.5 years after his traffic accident. He was diagnosed with spinal cord injury post trauma (T7-T9). It is the second time he was hospitalized.

[Case Analysis] Stem Cell Therapy for Parkinson's Disease (July 5, 2009) Drs. Xi, Wang and Wu

[Case Analysis] Stem Cell Therapy for Spinal Muscular Atrophy (July 9, 2009) Dr. Wu and Dr. Wang

[Case Analysis] Stem Cell Therapy for Cerebral Infarction (July 10, 2009) Drs. Liu, Wang and Wu